ALFA Finder| Metric | H1 FY27 | H2 FY26 | H1 FY26 |
|---|---|---|---|
| Revenue from operations | 55.3 | 63.0 | 48.8 |
| Other income | 1.7 | 0.0 | 3.3 |
| Total income | 57.0 | 63.0 | 52.1 |
| Profit before exceptional items & tax | 10.1 | 9.1 | 8.8 |
| Profit before tax | 10.1 | 9.1 | 8.8 |
| Net profit | 9.0 | 6.8 | 8.1 |
| Operating margin | 17.7% | 14.4% | 16.9% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +11.10% |
|---|---|
| Net profit, quarter on quarter | +32.40% |
| Revenue, year on year | +13.30% |
| Operating profit, year on year | +52.70% |
| Operating profit, quarter on quarter | -7.70% |
NSE results filing, NSE: QUESTLAB. Figures extracted from the filing.
Quest Laboratories Ltd: key numbers
- Share price
- ₹90.00
- Market cap
- ₹147.5 Cr
- Revenue (annual)
- ₹111.8 Cr
- Net profit (annual)
- ₹15.02 Cr
- P/E (TTM)
- 9.8×Sector 43.8×
- Promoter holding
- 66.78%+0.00% QoQ
- FII holding
- 0.66%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Quest Laboratories Ltd
All →Quest Laboratories Other Announcement
Quest Laboratories reported no deviation in IPO fund utilisation for the half year ended September 2026. Its statement was reviewed by the Audit Committee.
Quest Laboratories Annual General Meeting
Quest Laboratories Limited held its 28th Annual General Meeting on September 30, 2026. The company discussed and placed standard business resolutions for shareholder consideration and approval.
Quest Laboratories Partnership
Quest Laboratories Limited entered a strategic advisory collaboration with Niraga Capitals Private Limited to support its growth, corporate development, and strategic initiatives.
Quest Laboratories Business Update
Quest Laboratories updated its third-quarter business position, reporting export orders of ₹10.71 Crore and domestic sales of ₹16.90 Crore, with a total order book of ₹39.73 Crore.
- Order book
- ₹39.73 Cr
Quest Laboratories Capacity Expansion
Quest Laboratories Limited completed its Phase-I manufacturing expansion, with a new 12,000 sq. ft. facility becoming operational in September 2026.
- building expansion area
- 12000.0 sq. ft.
Quest Laboratories Annual General Meeting
Quest Laboratories Limited has scheduled its 28th Annual General Meeting for September 30, 2026, to transact agenda items including financial statements and director appointments.